BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suzuki K, Tamaru J, Okuyama A, Kameda H, Amano K, Nagasawa H, Nishi E, Yoshimoto K, Setoyama Y, Kaneko K, Osada H, Honda N, Sasaki Y, Itoyama S, Tsuzaka K, Takeuchi T. IgG4-positive multi-organ lymphoproliferative syndrome manifesting as chronic symmetrical sclerosing dacryo-sialadenitis with subsequent secondary portal hypertension and remarkable IgG4-linked IL-4 elevation. Rheumatology 2010;49:1789-91. [DOI: 10.1093/rheumatology/keq113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Uchida K, Okazaki K. Current status of type 1 (IgG4-related) autoimmune pancreatitis. J Gastroenterol 2022. [PMID: 35916965 DOI: 10.1007/s00535-022-01891-7] [Reference Citation Analysis]
2 Ibrahem HM. T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis. Autoimmune Dis 2022;2022:5689883. [PMID: 35769404 DOI: 10.1155/2022/5689883] [Reference Citation Analysis]
3 Liu J, Yin W, Westerberg LS, Lee P, Gong Q, Chen Y, Dong L, Liu C. Immune Dysregulation in IgG4-Related Disease. Front Immunol 2021;12:738540. [PMID: 34539675 DOI: 10.3389/fimmu.2021.738540] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Sohn KH, Ham J, Chung SJ, Kang HR, Kim HY. Analysis of Innate and Adaptive Immunological Characteristics in Patients with IgG4-Related Disease. Int Arch Allergy Immunol 2020;181:807-12. [PMID: 32629450 DOI: 10.1159/000508699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Umehara H, Okazaki K, Kawano M, Tanaka Y. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? Modern Rheumatology 2019;29:214-8. [DOI: 10.1080/14397595.2018.1558519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
6 Uchida K, Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol. 2018;53:475-483. [PMID: 29460239 DOI: 10.1007/s00535-018-1440-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
7 Yadlapati S, Verheyen E, Efthimiou P. IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 2018;38:169-77. [PMID: 28681251 DOI: 10.1007/s00296-017-3765-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
8 Akiyama M, Suzuki K, Yasuoka H, Kaneko Y, Yamaoka K, Takeuchi T. Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology 2018;57:236-45. [DOI: 10.1093/rheumatology/kex171] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 7.6] [Reference Citation Analysis]
9 Gospodarev V, Câmara J, Chakravarthy V, Perry A, Wood M, Dietz R, Wang J, De Los Reyes K, Raghavan R. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab. Journal of Neuroimmunology 2016;299:62-5. [DOI: 10.1016/j.jneuroim.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Kubo K, Yamamoto K. IgG4-related disease. Int J Rheum Dis 2016;19:747-62. [DOI: 10.1111/1756-185x.12586] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Umehara H, Nakajima A, Nakamura T, Kawanami T, Tanaka M, Dong L, Kawano M. IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol 2014;26:585-95. [PMID: 25024397 DOI: 10.1093/intimm/dxu074] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
12 Perez Alamino R, Martínez C, Espinoza LR. IgG4-associated vasculitis. Curr Rheumatol Rep 2013;15:348. [PMID: 23794082 DOI: 10.1007/s11926-013-0348-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
13 Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatology 2014;22:1-14. [DOI: 10.3109/s10165-011-0508-6] [Cited by in Crossref: 434] [Cited by in F6Publishing: 218] [Article Influence: 54.3] [Reference Citation Analysis]
14 Perez Alamino R, Espinoza LR, Zea AH. The great mimicker: IgG4-related disease. Clin Rheumatol 2013;32:1267-73. [PMID: 23877485 DOI: 10.1007/s10067-013-2326-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
15 Zen Y, Liberal R, Nakanuma Y, Heaton N, Portmann B. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J Hepatol. 2013;59:1059-1064. [PMID: 23811304 DOI: 10.1016/j.jhep.2013.06.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
16 Bhatti RM, Stelow EB. IgG4-related disease of the head and neck. Adv Anat Pathol 2013;20:10-6. [PMID: 23232567 DOI: 10.1097/PAP.0b013e31827b619e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
17 Zen Y, Bogdanos DP, Kawa S. Type 1 autoimmune pancreatitis. Orphanet J Rare Dis. 2011;6:82. [PMID: 22151922 DOI: 10.1186/1750-1172-6-82] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
18 Ebbo M, Grados A, Daniel L, Vély F, Harlé JR, Pavic M, Schleinitz N. IgG4-related systemic disease: emergence of a new systemic disease? Literature review. Rev Med Interne. 2012;33:23-34. [PMID: 21955722 DOI: 10.1016/j.revmed.2011.08.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
19 Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D; Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1-14. [PMID: 21881964 DOI: 10.1007/s10165-011-0508-6] [Cited by in Crossref: 96] [Cited by in F6Publishing: 225] [Article Influence: 8.7] [Reference Citation Analysis]
20 Zen Y, Nakanuma Y. IgG4 Cholangiopathy. Int J Hepatol. 2012;2012:472376. [PMID: 21994885 DOI: 10.1155/2012/472376] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
21 Watanabe T, Fujinaga Y, Kawakami S, Hatta T, Hamano H, Kawa S, Kadoya M. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol 2011;29:194-201. [PMID: 21519993 DOI: 10.1007/s11604-010-0539-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
22 Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol. 2011;23:114-118. [PMID: 21045701 DOI: 10.1097/bor.0b013e3283412f4a] [Cited by in Crossref: 95] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
23 . Current world literature. Curr Opin Rheumatol 2011;23:125-30. [PMID: 21124095 DOI: 10.1097/BOR.0b013e3283422cce] [Reference Citation Analysis]